SAj_AMERSA

Substance Use & Addiction journal (SAj) disseminates addiction-related research, policy positions, & commentary. Impact Factor: 2.8. Tweets&ReTweets are our own

[SAj_AMERSA @SAj_AMERSA]

SAj's AuthorsOwnWords: Redesigning a Stopped Clinical Trial as an Emulated Trial Using Real-World Data to Explore the Effectiveness of Slow-Release Oral Morphine as a Treatment for Opioid Use Disorder: This commentary aims to help other researchers and trialists apply emulated trials in substance use research and beyond, emphasizing the role of this methodology in clinical research and advancing scientific knowledge that could be otherwise lost or unattainable. https://t.co/V1laNMqKuH. .

[SAj_AMERSA @SAj_AMERSA]

SAj's AuthorsOwnWords: A Hospital-Based Intervention to Improve Access to #Buprenorphine for Patients with #OpioidUseDisorder "This paper describes a novel, volunteer physician-led interprofessional approach to identifying patients with OUD, initiating buprenorphine, and linking to office-based opioid treatment." https://t.co/Ww3Eky4d3X

[SAj_AMERSA @SAj_AMERSA]

SAj's AuthorsOwnWords: Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration "The proportions of patients with #OUD prescribed #MOUD increased from before to during the pandemic. However, Veterans who were women, Black, Latinx, and food insecure did not experience these increases."

https://t.co/xuGGZJrWXO

[SAj_AMERSA @SAj_AMERSA]

AuthorsOwnWords: The Lookout Project: A Student-Run Mail-Based Overdose Response Kit Distribution Program Through Social Media During COVID-19: "... nonprofit organization founded by college students, shows potential for informing other student-run organizations about naloxone distribution programs using social media advertising." https://t.co/sIHj0sUcNp

[AMERSA @AMERSA_tweets]

What a start! Today’s Opening Plenary energized the room and launched #AMERSA2025 with purpose.

[AMERSA @AMERSA_tweets]

Welcome to Day 1! We’re officially kicking off #AMERSA2025 — let’s make it an inspiring week together.

[AMERSA @AMERSA_tweets]

The AMERSA team is hard at work preparing for an inspiring week of connection, learning, and community at #AMERSA2025. Check in early today from 12-6pm or tomorrow from 7am-7pm to be entered into a drawing to win complimentary 2026 registration in Washington, DC!

[SAj_AMERSA @SAj_AMERSA]

"Screening for Nonmedical Use and Misuse of Prescription Medication by #Adolescents" : "Rates of reporting the nonmedical use of prescription medication or prescription medication misuse vary by screen, and some exceed national estimates. Nonmedical use of prescription medication or prescription medication misuse may be more common than previously reported..."

https://t.co/iOGi4GG6T5

[SAj_AMERSA @SAj_AMERSA]

"Psychosocial Impact of Suspected #Xylazine Associated Skin Wounds Among People Using #Fentanyl, Philadelphia, 2022 to 2023" - "People with probable #xylazine-associated skin wounds have psychosocial concerns about and self-treat these wounds."
https://t.co/X4ifhRt5cG

[SAj_AMERSA @SAj_AMERSA]

Practice Changes 6 Months Following a Physical Therapist Training Program Regarding Opioid Use and Misuse Screening and Assessment: A Qualitative Study: "...participants found the training important and useful and strengthened their perceptions of physical therapists’ role in screening for opioid misuse."

https://t.co/FowMd7d3Ak

[SAj_AMERSA @SAj_AMERSA]

"One Third of Alcohol Use Disorder Diagnoses are Missed by ICD Coding": "Our model improves the identification of patients meeting AUD criteria, outperforming ICD codes in detecting cases of AUD. Detection discrepancy...highlights clinician under documentation.."
https://t.co/ESDpCNfB3G

[SAj_AMERSA @SAj_AMERSA]

"State Policies Targeting Patient Brokering and Deceptive Marketing of Substance Use Disorder Treatment" - "State policies targeting patient brokering and deceptive marketing may be useful for preventing instances of unethical SUD treatment practices..."
https://t.co/zfIHYrM2SV

[SAj_AMERSA @SAj_AMERSA]

"Impact of a Web-Based Curriculum on Internal Medicine Resident Use of #Stigmatizing Language for Substance Use Disorder" - "There were trends toward improvement in language, including decreased use of stigmatizing terminology...."

https://t.co/9tnU7u9OlK

[SAj_AMERSA @SAj_AMERSA]

“SafetyNet”: Evaluation of a #RecoveryCoach and Paramedic Intervention Following Naloxone Resuscitation From an #OpioidOverdose" - "...We conducted a prospective nonrandomized study in individuals who experienced opioid overdoses, received ##naloxone..."

https://t.co/KYt99DHAiX

[SAj_AMERSA @SAj_AMERSA]

Exploring Xylazine Awareness, Health Impacts, and Harm Reduction Strategies: Findings From a Multimethods Study in Lowell, Massachusetts: "...there is limited awareness of #xylazine among #PWUD, and they consider xylazine an unwanted adulterant."

https://t.co/TgvdT106TG

[SAj_AMERSA @SAj_AMERSA]

Development of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis (IDU-IE): "A patient and clinician-informed website on IDU-IE is acceptable for patients and clinicians to use as a patient education resource to help prevent IDU-IE-related harms." https://t.co/L1GsbFjy5I

[SAj_AMERSA @SAj_AMERSA]

Association Between Length of #Buprenorphine or #Methadone Use and Nonprescribed Opioid Use Among Individuals with #OpioidUseDisorder: A Cohort Study. "...with each additional treatment month since baseline, those who continued with treatment appeared to be more likely to report 17% to 25% decreased odds of past 30-day nonprescribed opioid use." https://t.co/r6oTdAIqCz

[SAj_AMERSA @SAj_AMERSA]

"Our findings show that individuals in recovery from #SUD had highly + experiences with the episodic resonant breathing app. A + user experience may improve adherence to the intervention & the self-management of stress, anxiety, and craving relapse triggers." https://t.co/01m5mox7Fx